Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-05-004893
Filing Date
2005-04-22
Accepted
2005-04-22 17:51:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 y08089sv3.txt S-3 104748
2 EX-4.1: FORM OF DEED OF SHARE EXCHANGE y08089exv4w1.txt EX-4.1 54291
3 EX-4.2: FORM OF DEED OF SHARE EXCHANGE y08089exv4w2.txt EX-4.2 53373
4 EX-5.1: OPINION OF SAUL EWING LLP y08089exv5w1.txt EX-5.1 3257
5 EX-23.1: CONSENT OF KPMG LLP y08089exv23w1.txt EX-23.1 1685
  Complete submission text file 0000950123-05-004893.txt   218938
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: S-3 | Act: 33 | File No.: 333-124279 | Film No.: 05768381
SIC: 2835 In Vitro & In Vivo Diagnostic Substances